{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:44:03Z","timestamp":1791233043643,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While only 15\u201325 percent of melanoma patients develop distant metastasis and die, this disease is still responsible for the majority of skin cancer-related deaths. The availability of adjuvant therapies makes the selection of high-risk patients essential. We evaluated the intratumoral expression of ten miRNAs in primary melanomas in relation to its ability to predict melanoma survival. To this end, we correlated miRNA expression in 132 cryopreserved primary and metastatic tumors with clinicopathological factors and clinical outcome. We found sequential downregulation of intratumoral expression of miR-125b, miR-182, miR-200c and miR-205 over the full spectrum of melanoma progression. Moreover, downregulation of these miRNAs occurred in primary melanomas that further disseminated to distant sites. Furthermore, miR-125b, miR-200c and miR-205 correlated as independent factors with shorter survival. Our <jats:italic>in vitro<\/jats:italic> findings demonstrate that loss of miR-205 potentiates the invasive ability of melanoma cells. We conclude that the downregulation of miR-205 in primary melanomas is an intrinsic property that might contribute to distant metastasis. In particular, the interaction of melanoma cells with the extracellular matrix is one of the key mechanisms by which miR-205 influences melanoma metastasis. In conclusion, miR-125b, miR-200c and miR-205 are useful prognostic biomarkers at the time of diagnosis to select high-risk patients.<\/jats:p>","DOI":"10.1038\/s41598-018-35317-3","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T10:37:51Z","timestamp":1542191871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival"],"prefix":"10.1038","volume":"8","author":[{"given":"Beatriz","family":"S\u00e1nchez-Sendra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Martinez-Ciarpaglini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9832-3355","authenticated-orcid":false,"given":"Jos\u00e9 F.","family":"Gonz\u00e1lez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Murgui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liria","family":"Terr\u00e1dez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Monteagudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"35317_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2017. CA Cancer J Clin 67, 7\u201330 (2017).","journal-title":"CA Cancer J Clin"},{"key":"35317_CR2","unstructured":"Gershenwald, J. E. et al. Melanoma of the skin in AJCC Cancer Staging Manual, 8th ed (ed. Amin, M. B.) 563\u2013585 (Springer, 2017)."},{"key":"35317_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"35317_CR4","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1038\/sj.onc.1209911","volume":"25","author":"T Dalmay","year":"2006","unstructured":"Dalmay, T. & Edwards, D. R. MicroRNAs and the hallmarks of cancer. Oncogene 25, 6170\u20136175 (2006).","journal-title":"Oncogene"},{"key":"35317_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"35317_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1152\/physiolgenomics.00116.2013","volume":"45","author":"PE Bennett","year":"2013","unstructured":"Bennett, P. E. et al. miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma. Physiol Genomics 45, 1049\u20131059 (2013).","journal-title":"Physiol Genomics"},{"key":"35317_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell 116, 281\u2013297 (2004).","journal-title":"Cell"},{"key":"35317_CR8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834\u2013838 (2005).","journal-title":"Nature"},{"key":"35317_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/jclinpath-2015-203537","volume":"70","author":"M Martinez-Rodriguez","year":"2017","unstructured":"Martinez-Rodriguez, M., Thompson, A. K. & Monteagudo, C. High CCL27 immunoreactivity in \u201csupratumoral\u201d epidermis correlates with better prognosis in patients with cutaneous malignant melanoma. J Clin Pathol 70, 15\u201319 (2017).","journal-title":"J Clin Pathol"},{"key":"35317_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.suronc.2016.05.017","volume":"25","author":"N Latchana","year":"2016","unstructured":"Latchana, N., Ganju, A., Howard, J. H. & Carson, W. E. MicroRNA dysregulation in melanoma. Surg Oncol 25, 184\u2013189 (2016).","journal-title":"Surg Oncol"},{"key":"35317_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejca.2015.10.009","volume":"53","author":"H Mirzaei","year":"2016","unstructured":"Mirzaei, H. et al. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. Eur J Cancer 53, 25\u201332 (2016).","journal-title":"Eur J Cancer"},{"key":"35317_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/JID.2015.355","volume":"136","author":"K Jayawardana","year":"2016","unstructured":"Jayawardana, K. et al. Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma. J Invest Dermatol 136, 245\u2013254 (2016).","journal-title":"J Invest Dermatol"},{"key":"35317_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/bjd.12989","volume":"171","author":"V Sun","year":"2014","unstructured":"Sun, V., Zhou, W. B., Majid, S., Kashani-Sabet, M. & Dar, A. A. MicroRNA-mediated regulation of melanoma. Br J Dermatol 171, 234\u2013241 (2014).","journal-title":"Br J Dermatol"},{"key":"35317_CR14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.clinbiochem.2013.01.008","volume":"46","author":"D V\u00f6ller","year":"2013","unstructured":"V\u00f6ller, D., Ott, C. & Bosserhoff, A. MicroRNAs in malignant melanoma. Clin Biochem 46, 909\u2013917 (2013).","journal-title":"Clin Biochem"},{"key":"35317_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1468-3083.2012.04579.x","volume":"27","author":"M Glud","year":"2013","unstructured":"Glud, M. & Gniadecki, R. MicroRNAs in the pathogenesis of malignant melanoma. J Eur Acad Dermatol Venereol 27, 142\u2013150 (2013).","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"35317_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-94-007-5590-1_6","volume":"774","author":"M Kunz","year":"2013","unstructured":"Kunz, M. MicroRNAs in melanoma biology. Adv Exp Med Biol 774, 103\u2013120 (2013).","journal-title":"Adv Exp Med Biol"},{"key":"35317_CR17","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/carcin\/bgs205","volume":"33","author":"MF Segura","year":"2012","unstructured":"Segura, M. F., Greenwald, H. S., Hanniford, D., Osman, I. & Hernando, E. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Carcinogenesis 33, 1823\u20131832 (2012).","journal-title":"Carcinogenesis"},{"key":"35317_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/CMR.0b013e32834f6fbb","volume":"22","author":"VF Bonazzi","year":"2012","unstructured":"Bonazzi, V. F., Stark, M. S. & Hayward, N. K. MicroRNA regulation of melanoma progression. Melanoma Res 22, 101\u2013113 (2012).","journal-title":"Melanoma Res"},{"key":"35317_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00428-012-1309-9","volume":"461","author":"LC van Kempen","year":"2012","unstructured":"van Kempen, L. C. et al. Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression. Virchows Arch 461, 441\u2013448 (2012).","journal-title":"Virchows Arch"},{"key":"35317_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10, 593\u2013601 (2008).","journal-title":"Nat Cell Biol"},{"key":"35317_CR21","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/labinvest.2012.119","volume":"92","author":"JA Hanna","year":"2012","unstructured":"Hanna, J. A., Hahn, L., Agarwal, S. & Rimm, D. L. In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA. Lab Invest 92, 1390\u20131397 (2012).","journal-title":"Lab Invest"},{"key":"35317_CR22","doi-asserted-by":"publisher","first-page":"16606","DOI":"10.1074\/jbc.M111.227611","volume":"286","author":"AA Dar","year":"2011","unstructured":"Dar, A. A. et al. miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem 286, 16606\u201316614 (2011).","journal-title":"J Biol Chem"},{"key":"35317_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/CMR.0b013e32833e32a1","volume":"20","author":"M Glud","year":"2010","unstructured":"Glud, M. et al. Downregulation of miR-125b in metastatic cutaneous malignant melanoma. Melanoma Res 20, 479\u2013484 (2010).","journal-title":"Melanoma Res"},{"key":"35317_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/pcmr.12179","volume":"27","author":"KH Kim","year":"2014","unstructured":"Kim, K. H. et al. Novel inhibitory function of miR-125b in melanogenesis. Pigment Cell Melanoma Res 27, 140\u2013144 (2014).","journal-title":"Pigment Cell Melanoma Res"},{"key":"35317_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/CMR.0b013e328345333b","volume":"21","author":"M Glud","year":"2011","unstructured":"Glud, M. et al. MicroRNA miR-125b induces senescence in human melanoma cells. Melanoma Res 21, 253\u2013256 (2011).","journal-title":"Melanoma Res"},{"key":"35317_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-5945-14-8","volume":"14","author":"AM Nyholm","year":"2014","unstructured":"Nyholm, A. M. et al. miR-125b induces celular senescence in malignant melanoma. BMC Dermatol 14, 8 (2014).","journal-title":"BMC Dermatol"},{"key":"35317_CR27","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1038\/onc.2012.307","volume":"32","author":"M Kappelmann","year":"2013","unstructured":"Kappelmann, M., Kuphal, S., Meister, G., Vardimon, L. & Bosserhoff, A. K. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression. Oncogene 32, 2984\u20132991 (2013).","journal-title":"Oncogene"},{"key":"35317_CR28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/ced.12286","volume":"39","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. MLK3 promotes melanoma proliferation and invasion and is a target of microRNA-125b. Clin Exp Dermatol 39, 376\u2013384 (2014).","journal-title":"Clin Exp Dermatol"},{"key":"35317_CR29","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1007\/s13277-015-4409-8","volume":"37","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. MicroRNA-125b suppresses the epitelial-mesenchymal transition and cell invasion by targeting ITGA9 in melanoma. Tumour Biol 37, 5941\u20135949 (2016).","journal-title":"Tumour Biol"},{"key":"35317_CR30","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/labinvest.2012.62","volume":"92","author":"S Liu","year":"2012","unstructured":"Liu, S. et al. Loss of microRNA-205 expression is associated with melanoma progression. Lab Invest 92, 1084\u20131096 (2012).","journal-title":"Lab Invest"},{"key":"35317_CR31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/bjc.2011.568","volume":"106","author":"Y Xu","year":"2012","unstructured":"Xu, Y., Brenn, T., Brown, E. R., Doherty, V. & Melton, D. W. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour supressors. Br J Cancer 106, 553\u2013561 (2012).","journal-title":"Br J Cancer"},{"key":"35317_CR32","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 161, 1681\u20131696 (2015).","DOI":"10.1016\/j.cell.2015.05.044"},{"key":"35317_CR33","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jid.2017.09.049","volume":"138","author":"W Lohcharoenkal","year":"2018","unstructured":"Lohcharoenkal, W. et al. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis. J Invest Dermatol 138, 882\u2013892 (2018).","journal-title":"J Invest Dermatol"},{"key":"35317_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gki140","volume":"33","author":"C Chen","year":"2005","unstructured":"Chen, C. et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33, 1\u20139 (2005).","journal-title":"Nucleic Acids Res"},{"key":"35317_CR35","first-page":"413","volume":"5","author":"J Le Carr\u00e9","year":"2014","unstructured":"Le Carr\u00e9, J., Lamon, S. & L\u00e9ger, B. Validation of a multiplex reverse transcription and pre-amplification method using TaqMan MicroRNA assays. Front Genet 5, 413 (2014).","journal-title":"Front Genet"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35317-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35317-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35317-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:44:19Z","timestamp":1671623059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35317-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35317"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35317-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"15 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17076"}}